Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Shares Outstanding (Weighted Average) (2016 - 2018)

Historic Shares Outstanding (Weighted Average) for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $4.7 million.

  • Armata Pharmaceuticals' Shares Outstanding (Weighted Average) fell 4757.32% to $4.7 million in Q3 2018 from the same period last year, while for Sep 2018 it was $4.7 million, marking a year-over-year decrease of 4757.32%. This contributed to the annual value of $6.4 million for FY2017, which is 54923.02% up from last year.
  • Per Armata Pharmaceuticals' latest filing, its Shares Outstanding (Weighted Average) stood at $4.7 million for Q3 2018, which was down 4757.32% from $4.7 million recorded in Q2 2018.
  • In the past 5 years, Armata Pharmaceuticals' Shares Outstanding (Weighted Average) registered a high of $182.5 million during Q1 2014, and its lowest value of $588350.0 during Q1 2016.
  • Over the past 5 years, Armata Pharmaceuticals' median Shares Outstanding (Weighted Average) value was $4.7 million (recorded in 2018), while the average stood at $13.9 million.
  • As far as peak fluctuations go, Armata Pharmaceuticals' Shares Outstanding (Weighted Average) crashed by 9767.4% in 2015, and later soared by 69806.67% in 2017.
  • Over the past 5 years, Armata Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarter) stood at $3.7 million in 2014, then soared by 44.43% to $5.4 million in 2015, then crashed by 81.82% to $983846.0 in 2016, then soared by 549.23% to $6.4 million in 2017, then decreased by 27.16% to $4.7 million in 2018.
  • Its Shares Outstanding (Weighted Average) stands at $4.7 million for Q3 2018, versus $4.7 million for Q2 2018 and $13.3 million for Q1 2018.